Literature DB >> 12810543

Reactive oxygen disrupts mitochondria in MA-10 tumor Leydig cells and inhibits steroidogenic acute regulatory (StAR) protein and steroidogenesis.

Thorsten Diemer1, John A Allen, Karen Held Hales, Dale Buchanan Hales.   

Abstract

Reactive oxygen species (ROS) are involved in a variety of pathophysiological conditions of the testis, and oxidative stress is known to inhibit ovarian and testicular steroidogenesis. The site of ROS-mediated inhibition of steroidogenesis in the corpus luteum and MA-10 tumor Leydig cells was shown to be the hormone-sensitive mitochondrial cholesterol transfer step. The purpose of this study was to examine the effects of ROS on steroidogenic acute regulatory (StAR) protein in MA-10 cells and determine the extent to which MA-10 cell mitochondria are sensitive to oxidative stress. cAMP-stimulated progesterone production was inhibited in a dose-dependent manner in MA-10 cells exposed to H(2)O(2). StAR protein, but not mRNA levels, was decreased in parallel to changes in progesterone production. Even at the highest concentrations of H(2)O(2) tested, there was no effect on P450 side-chain cleavage enzyme protein levels. Oxidative stress from exposure to exogenous xanthine oxidase and xanthine resulted in the inhibition of both progesterone production and StAR protein expression. The mature 30- and 32-kDa intramitochondrial forms of StAR were decreased relative to the 37-kDa extramitochondrial precursor form of StAR, indicating that the ROS-mediated inhibition of StAR protein was due, in part, to the inhibition of mitochondrial import and processing. Vital staining with the fluorescent dye tetramethylrhodamine ethyl ester was used to visualize changes in the mitochondrial electrochemical gradient-dependent membrane potential (Deltapsim). ROS caused a significant dissipation of Deltapsi(m) and time-dependent loss of tetramethylrhodamine ethyl ester fluorescence. The inhibitory effects of H(2)O(2) were transient. There was no evidence for ROS-induced cell death, and following H(2)O(2) removal in the presence of continuous treatment with 8-bromo-cAMP, StAR protein levels and progesterone production were restored. In addition, there was no loss of cell viability following treatment with H(2)O(2) or xanthine/xanthine oxidase as determined by trypan blue exclusion. H(2)O(2) did not cause a significant decrease in total cellular ATP levels. These data indicate that oxidative stress-mediated perturbation of the mitochondria and dissipation of Deltapsi(m) results in the inhibition of StAR protein expression and its import, processing, and cholesterol transfer activity. These findings confirm earlier studies demonstrating the requirement for maintenance of an intact Deltapsi(m) for StAR protein function in cholesterol transport. The significant reduction in the 32- to 30-kDa mature forms of StAR, cessation of cholesterol transport, and loss of Deltapsi(m) are consistent with mitochondrial perturbation because of oxidative stress. This mechanism likely contributes to a host of pathophysiological events evident in testicular disorders such as infection, reperfusion injury, aging, cryptorchidism, and varicocele.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810543     DOI: 10.1210/en.2002-0090

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  70 in total

1.  Low-dose gold nanoparticles exert subtle endocrine-modulating effects on the ovarian steroidogenic pathway ex vivo independent of oxidative stress.

Authors:  Jeremy K Larson; Michael J Carvan; Justin G Teeguarden; Gen Watanabe; Kazuyoshi Taya; Evan Krystofiak; Reinhold J Hutz
Journal:  Nanotoxicology       Date:  2014-12       Impact factor: 5.913

Review 2.  Role of the steroidogenic acute regulatory protein in health and disease.

Authors:  Pulak R Manna; Cloyce L Stetson; Andrzej T Slominski; Kevin Pruitt
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

3.  Rat brain endothelial cells are a target of manganese toxicity.

Authors:  Ana Paula Marreilha dos Santos; Dejan Milatovic; Catherine Au; Zhaobao Yin; Maria Camila C Batoreu; Michael Aschner
Journal:  Brain Res       Date:  2010-02-17       Impact factor: 3.252

4.  [Research in urologic university clinics. Assessment of current status and perspectives].

Authors:  K Miller; H Krause
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

5.  TNF-α-mediated suppression of Leydig cell steroidogenesis involves DAX-1.

Authors:  Mohanraj Sadasivam; Balamurugan Ramatchandirin; Sivasangari Balakrishnan; Chidambaram Prahalathan
Journal:  Inflamm Res       Date:  2015-06-06       Impact factor: 4.575

6.  HDAC7 modulates TNF-α-mediated suppression of Leydig cell steroidogenesis.

Authors:  Mohanraj Sadasivam; Balamurugan Ramatchandirin; Sivasangari Balakrishnan; Chidambaram Prahalathan
Journal:  Mol Cell Biochem       Date:  2015-04-28       Impact factor: 3.396

7.  Bacterial endotoxin lipopolysaccharide and reactive oxygen species inhibit Leydig cell steroidogenesis via perturbation of mitochondria.

Authors:  John A Allen; Thorsten Diemer; Paul Janus; Karen Held Hales; Dale B Hales
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

8.  Effect of glutathione depletion on Leydig cell steroidogenesis in young and old brown Norway rats.

Authors:  Haolin Chen; Angela S Pechenino; June Liu; Matthew C Beattie; Terry R Brown; Barry R Zirkin
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

9.  StarD4-mediated translocation of 7-hydroperoxycholesterol to isolated mitochondria: deleterious effects and implications for steroidogenesis under oxidative stress conditions.

Authors:  Witold Korytowski; Daniel Rodriguez-Agudo; Anna Pilat; Albert W Girotti
Journal:  Biochem Biophys Res Commun       Date:  2010-01-06       Impact factor: 3.575

10.  Effects of benzo(a)pyrene on intra-testicular function in F-344 rats.

Authors:  Anthony E Archibong; Aramandla Ramesh; Mohammad S Niaz; Cynthia M Brooks; Shannon I Roberson; Donald D Lunstra
Journal:  Int J Environ Res Public Health       Date:  2008-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.